Copyright Reports & Markets. All rights reserved.

Global Vaccine Contract Manufacturing Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Vaccine Contract Manufacturing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Fill-Finish
    • 1.2.3 Bulk Product
  • 1.3 Market by Application
    • 1.3.1 Global Vaccine Contract Manufacturing Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Pharmaceutical Companies
    • 1.3.3 Biotech Companies
    • 1.3.4 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Vaccine Contract Manufacturing Market Perspective (2016-2027)
  • 2.2 Vaccine Contract Manufacturing Growth Trends by Regions
    • 2.2.1 Vaccine Contract Manufacturing Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Vaccine Contract Manufacturing Historic Market Share by Regions (2016-2021)
    • 2.2.3 Vaccine Contract Manufacturing Forecasted Market Size by Regions (2022-2027)
  • 2.3 Vaccine Contract Manufacturing Industry Dynamic
    • 2.3.1 Vaccine Contract Manufacturing Market Trends
    • 2.3.2 Vaccine Contract Manufacturing Market Drivers
    • 2.3.3 Vaccine Contract Manufacturing Market Challenges
    • 2.3.4 Vaccine Contract Manufacturing Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Vaccine Contract Manufacturing Players by Revenue
    • 3.1.1 Global Top Vaccine Contract Manufacturing Players by Revenue (2016-2021)
    • 3.1.2 Global Vaccine Contract Manufacturing Revenue Market Share by Players (2016-2021)
  • 3.2 Global Vaccine Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Vaccine Contract Manufacturing Revenue
  • 3.4 Global Vaccine Contract Manufacturing Market Concentration Ratio
    • 3.4.1 Global Vaccine Contract Manufacturing Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Vaccine Contract Manufacturing Revenue in 2020
  • 3.5 Vaccine Contract Manufacturing Key Players Head office and Area Served
  • 3.6 Key Players Vaccine Contract Manufacturing Product Solution and Service
  • 3.7 Date of Enter into Vaccine Contract Manufacturing Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Vaccine Contract Manufacturing Breakdown Data by Type

  • 4.1 Global Vaccine Contract Manufacturing Historic Market Size by Type (2016-2021)
  • 4.2 Global Vaccine Contract Manufacturing Forecasted Market Size by Type (2022-2027)

5 Vaccine Contract Manufacturing Breakdown Data by Application

  • 5.1 Global Vaccine Contract Manufacturing Historic Market Size by Application (2016-2021)
  • 5.2 Global Vaccine Contract Manufacturing Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Vaccine Contract Manufacturing Market Size (2016-2027)
  • 6.2 North America Vaccine Contract Manufacturing Market Size by Type
    • 6.2.1 North America Vaccine Contract Manufacturing Market Size by Type (2016-2021)
    • 6.2.2 North America Vaccine Contract Manufacturing Market Size by Type (2022-2027)
    • 6.2.3 North America Vaccine Contract Manufacturing Market Size by Type (2016-2027)
  • 6.3 North America Vaccine Contract Manufacturing Market Size by Application
    • 6.3.1 North America Vaccine Contract Manufacturing Market Size by Application (2016-2021)
    • 6.3.2 North America Vaccine Contract Manufacturing Market Size by Application (2022-2027)
    • 6.3.3 North America Vaccine Contract Manufacturing Market Size by Application (2016-2027)
  • 6.4 North America Vaccine Contract Manufacturing Market Size by Country
    • 6.4.1 North America Vaccine Contract Manufacturing Market Size by Country (2016-2021)
    • 6.4.2 North America Vaccine Contract Manufacturing Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.3 Canada

7 Europe

  • 7.1 Europe Vaccine Contract Manufacturing Market Size (2016-2027)
  • 7.2 Europe Vaccine Contract Manufacturing Market Size by Type
    • 7.2.1 Europe Vaccine Contract Manufacturing Market Size by Type (2016-2021)
    • 7.2.2 Europe Vaccine Contract Manufacturing Market Size by Type (2022-2027)
    • 7.2.3 Europe Vaccine Contract Manufacturing Market Size by Type (2016-2027)
  • 7.3 Europe Vaccine Contract Manufacturing Market Size by Application
    • 7.3.1 Europe Vaccine Contract Manufacturing Market Size by Application (2016-2021)
    • 7.3.2 Europe Vaccine Contract Manufacturing Market Size by Application (2022-2027)
    • 7.3.3 Europe Vaccine Contract Manufacturing Market Size by Application (2016-2027)
  • 7.4 Europe Vaccine Contract Manufacturing Market Size by Country
    • 7.4.1 Europe Vaccine Contract Manufacturing Market Size by Country (2016-2021)
    • 7.4.2 Europe Vaccine Contract Manufacturing Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Vaccine Contract Manufacturing Market Size (2016-2027)
  • 8.2 Asia-Pacific Vaccine Contract Manufacturing Market Size by Type
    • 8.2.1 Asia-Pacific Vaccine Contract Manufacturing Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Vaccine Contract Manufacturing Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Vaccine Contract Manufacturing Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Vaccine Contract Manufacturing Market Size by Application
    • 8.3.1 Asia-Pacific Vaccine Contract Manufacturing Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Vaccine Contract Manufacturing Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Vaccine Contract Manufacturing Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Vaccine Contract Manufacturing Market Size by Region
    • 8.4.1 Asia-Pacific Vaccine Contract Manufacturing Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Vaccine Contract Manufacturing Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Vaccine Contract Manufacturing Market Size (2016-2027)
  • 9.2 Latin America Vaccine Contract Manufacturing Market Size by Type
    • 9.2.1 Latin America Vaccine Contract Manufacturing Market Size by Type (2016-2021)
    • 9.2.2 Latin America Vaccine Contract Manufacturing Market Size by Type (2022-2027)
    • 9.2.3 Latin America Vaccine Contract Manufacturing Market Size by Type (2016-2027)
  • 9.3 Latin America Vaccine Contract Manufacturing Market Size by Application
    • 9.3.1 Latin America Vaccine Contract Manufacturing Market Size by Application (2016-2021)
    • 9.3.2 Latin America Vaccine Contract Manufacturing Market Size by Application (2022-2027)
    • 9.3.3 Latin America Vaccine Contract Manufacturing Market Size by Application (2016-2027)
  • 9.4 Latin America Vaccine Contract Manufacturing Market Size by Country
    • 9.4.1 Latin America Vaccine Contract Manufacturing Market Size by Country (2016-2021)
    • 9.4.2 Latin America Vaccine Contract Manufacturing Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Vaccine Contract Manufacturing Market Size (2016-2027)
  • 10.2 Middle East & Africa Vaccine Contract Manufacturing Market Size by Type
    • 10.2.1 Middle East & Africa Vaccine Contract Manufacturing Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Vaccine Contract Manufacturing Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Vaccine Contract Manufacturing Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Vaccine Contract Manufacturing Market Size by Application
    • 10.3.1 Middle East & Africa Vaccine Contract Manufacturing Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Vaccine Contract Manufacturing Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Vaccine Contract Manufacturing Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Vaccine Contract Manufacturing Market Size by Country
    • 10.4.1 Middle East & Africa Vaccine Contract Manufacturing Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Vaccine Contract Manufacturing Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Diosynth
    • 11.1.1 Diosynth Company Details
    • 11.1.2 Diosynth Business Overview
    • 11.1.3 Diosynth Vaccine Contract Manufacturing Introduction
    • 11.1.4 Diosynth Revenue in Vaccine Contract Manufacturing Business (2016-2021)
    • 11.1.5 Diosynth Recent Development
  • 11.2 Emergent BioSolutions
    • 11.2.1 Emergent BioSolutions Company Details
    • 11.2.2 Emergent BioSolutions Business Overview
    • 11.2.3 Emergent BioSolutions Vaccine Contract Manufacturing Introduction
    • 11.2.4 Emergent BioSolutions Revenue in Vaccine Contract Manufacturing Business (2016-2021)
    • 11.2.5 Emergent BioSolutions Recent Development
  • 11.3 Goodwin Biotechnology
    • 11.3.1 Goodwin Biotechnology Company Details
    • 11.3.2 Goodwin Biotechnology Business Overview
    • 11.3.3 Goodwin Biotechnology Vaccine Contract Manufacturing Introduction
    • 11.3.4 Goodwin Biotechnology Revenue in Vaccine Contract Manufacturing Business (2016-2021)
    • 11.3.5 Goodwin Biotechnology Recent Development
  • 11.4 Bavarian Nordic
    • 11.4.1 Bavarian Nordic Company Details
    • 11.4.2 Bavarian Nordic Business Overview
    • 11.4.3 Bavarian Nordic Vaccine Contract Manufacturing Introduction
    • 11.4.4 Bavarian Nordic Revenue in Vaccine Contract Manufacturing Business (2016-2021)
    • 11.4.5 Bavarian Nordic Recent Development
  • 11.5 Soligenix Inc
    • 11.5.1 Soligenix Inc Company Details
    • 11.5.2 Soligenix Inc Business Overview
    • 11.5.3 Soligenix Inc Vaccine Contract Manufacturing Introduction
    • 11.5.4 Soligenix Inc Revenue in Vaccine Contract Manufacturing Business (2016-2021)
    • 11.5.5 Soligenix Inc Recent Development
  • 11.6 Catalent Biologics
    • 11.6.1 Catalent Biologics Company Details
    • 11.6.2 Catalent Biologics Business Overview
    • 11.6.3 Catalent Biologics Vaccine Contract Manufacturing Introduction
    • 11.6.4 Catalent Biologics Revenue in Vaccine Contract Manufacturing Business (2016-2021)
    • 11.6.5 Catalent Biologics Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Vaccine Contract Manufacturing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Vaccine Contract Manufacturing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Fill-Finish
    Bulk Product

    Segment by Application
    Pharmaceutical Companies
    Biotech Companies
    Others

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Diosynth
    Emergent BioSolutions
    Goodwin Biotechnology
    Bavarian Nordic
    Soligenix Inc
    Catalent Biologics
    Bavarian Nordic

    Buy now